Cardiovascular protection by Ca antagonists.
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D002319:Cardiovascular System / Q000187:drug effects*; D003329:Coronary Vasospasm / Q000517:prevention & control; D004110:Diltiazem / Q000494:pharmacology; D006973:Hypertension / Q000517:prevention & control; D066298:In Vitro Techniques; D009131:Muscle, Smooth, Vascular / Q000187:drug effects; D009543:Nifedipine / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D013552:Swine; D014700:Verapamil / Q000494:pharmacology
D002121:Calcium Channel Blockers; D014700:Verapamil; D004110:Diltiazem; D009543:Nifedipine